Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized antibodies against CD269 (BCMA)

Humanized antibodies against CD269 (BCMA)

US Patent 10144782 · Granted Dec 4, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor and CAR-T cells that bind BCMA2025
Extracorporeal devices for methods for treating diseases associated with anti-ne2024
Chimeric antigen receptor and CAR-T cells that bind BCMA2024
Humanized antibodies against CD269 (BCMA)2023
Humanized antibodies against CD269 (BCMA)2023
Humanized antibodies against CD269 (BCMA)2023
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2023
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2023
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2023
Gamma-carboline compounds for the detection of Tau aggregates2022
Compounds for imaging Tau protein aggregates2020
Humanized antibodies against CD269 (BCMA)2020